Immunotec Announces Third Quarter 2013 Financial Results
(firmenpresse) - VAUDREUIL-DORION, QUEBEC -- (Marketwired) -- 09/12/13 -- Immunotec Inc. (TSX VENTURE: IMM), a Canadian based company and a leader in the wellness industry (the "Company" or "Immunotec"), today released its third quarter 2013 financial results for the three- and nine-month periods ended 31 July 2013.
"Immunotec has concluded a strong quarter of growth, particularly in Mexico and the western United States. Sponsoring trended positively in all markets throughout the three-month period, reflecting the marketing outreach of the Company's independent consultants" said Mr. Charles L. Orr, Immunotec's Chief Executive Officer. "Additionally, we are commemorating this week, the research partnership initiated twenty five years ago leading to the discovery of Immunocal and the birth of our business in 1995".
Highlights for the third quarter of fiscal 2013
"We are pleased with the Net earnings after nine months, reflecting the field efforts to build shareholder value;" said Mr. Patrick Montpetit, Immunotec's Chief Financial Officer, "the net loss for the quarter is the result of the non-cash foreign exchange adjustments and non-cash deferred income tax charges."
About Immunotec Inc.
Immunotec is a world-class business opportunity supported by unique, scientifically proven products that improve wellness. Headquartered with manufacturing facilities near Montreal, Canada, the Company also has distribution capacities to support its commercial activities in Canada and internationally to the United States, Mexico, Europe and the Caribbean.
The Company files its consolidated financial statements, its management and discussion analysis report, its press releases and such other required documents on the SEDAR database at and on the Company's website at . The common shares of the Company are listed on the TSX Venture Exchange under the ticker symbol IMM.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
CAUTION REGARDING FORWARD-LOOKING STATEMENTS: Certain statements contained in this news release are forward-looking and are subject to numerous risks and uncertainties, known and unknown. For information identifying known risks and uncertainties and other important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the heading Risks and Uncertainties in Immunotec's most recent Management's Discussion and Analysis, which can be found at . Consequently, actual results may differ materially from the anticipated results expressed in these forward-looking statements.
SUPPLEMENTAL INFORMATION
Contacts:
Patrick Montpetit
Chief Financial Officer
(450) 510-4527
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 12.09.2013 - 20:38 Uhr
Sprache: Deutsch
News-ID 296264
Anzahl Zeichen: 0
contact information:
Town:
VAUDREUIL-DORION, QUEBEC
Kategorie:
Health & Nutrition
Diese Pressemitteilung wurde bisher 252 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Immunotec Announces Third Quarter 2013 Financial Results"
steht unter der journalistisch-redaktionellen Verantwortung von
Immunotec Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
